Mersana Therapeutics, Inc. (NASDAQ:MRSN) Sees Significant Decline in Short Interest

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 8,990,000 shares, a drop of 17.7% from the April 30th total of 10,920,000 shares. Based on an average trading volume of 2,150,000 shares, the days-to-cover ratio […]

Related Keywords

Robertw Baird , ,Jpmorgan Chase Co ,Merck Kgaa ,Asana Biosciences ,Acadian Asset Management ,Janssen Biotech Inc ,Russell Investments Group Ltd ,Mersana Therapeutics Company Profile ,Walleye Trading ,Nasdaq ,Mersana Therapeutics Inc ,Pricet Rowe Associates Inc ,Merck Kga ,Vanguard Group Inc ,Mersana Therapeutics ,Get Free Report ,Truist Financial ,Asset Management ,Russell Investments Group ,Investments Group ,Therapeutics Trading Down ,Janssen Biotech ,Ares Trading ,Mersana Therapeutics Daily ,